» Articles » PMID: 22530067

The P250GAP Gene is Associated with Risk for Schizophrenia and Schizotypal Personality Traits

Overview
Journal PLoS One
Date 2012 Apr 25
PMID 22530067
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hypofunction of the glutamate N-Methyl-d-aspartate (NMDA) receptor has been implicated in the pathophysiology of schizophrenia. p250GAP is a brain-enriched NMDA receptor-interacting RhoGAP. p250GAP is involved in spine morphology, and spine morphology has been shown to be altered in the post-mortem brains of patients with schizophrenia. Schizotypal personality disorder has a strong familial relationship with schizophrenia. Several susceptibility genes for schizophrenia have been related to schizotypal traits.

Methods: We first investigated the association of eight linkage disequilibrium-tagging single-nucleotide polymorphisms (SNPs) that cover the p250GAP gene with schizophrenia in a Japanese sample of 431 schizophrenia patients and 572 controls. We then investigated the impact of the risk genetic variant in the p250GAP gene on schizotypal personality traits in 180 healthy subjects using the Schizotypal Personality Questionnaire.

Results: We found a significant difference in genotype frequency between the patients and the controls in rs2298599 (χ(2) = 17.6, p = 0.00015). The minor A/A genotype frequency of rs2298599 was higher in the patients (18%) than in the controls (9%) (χ(2) = 15.5, p = 0.000083). Moreover, we found that subjects with the rs2298599 risk A/A genotype, compared with G allele carriers, had higher scores of schizotypal traits (F(1,178) = 4.08, p = 0.045), particularly the interpersonal factor (F(1,178) = 5.85, p = 0.017).

Discussion: These results suggest that a genetic variation in the p250GAP gene might increase susceptibility not only for schizophrenia but also for schizotypal personality traits. We concluded that the p250GAP gene might be a new candidate gene for susceptibility to schizophrenia.

Citing Articles

Identifying the differentially expressed peripheral blood microRNAs in psychiatric disorders: a systematic review and meta-analysis.

Liu X, Dong L, Jiang Z, Song M, Yan P Front Psychiatry. 2024; 15:1390366.

PMID: 38827444 PMC: 11140110. DOI: 10.3389/fpsyt.2024.1390366.


Genomic and Reverse Translational Analysis Discloses a Role for Small GTPase RhoA Signaling in the Pathogenesis of Schizophrenia: Rho-Kinase as a Novel Drug Target.

Tanaka R, Yamada K Int J Mol Sci. 2023; 24(21).

PMID: 37958606 PMC: 10648424. DOI: 10.3390/ijms242115623.


De novo single-nucleotide and copy number variation in discordant monozygotic twins reveals disease-related genes.

Vadgama N, Pittman A, Simpson M, Nirmalananthan N, Murray R, Yoshikawa T Eur J Hum Genet. 2019; 27(7):1121-1133.

PMID: 30886340 PMC: 6777616. DOI: 10.1038/s41431-019-0376-7.


Current Knowledge on Gene-Environment Interactions in Personality Disorders: an Update.

Bulbena-Cabre A, Bassir Nia A, Perez-Rodriguez M Curr Psychiatry Rep. 2018; 20(9):74.

PMID: 30094700 DOI: 10.1007/s11920-018-0934-7.


The Autism-Related Protein PX-RICS Mediates GABAergic Synaptic Plasticity in Hippocampal Neurons and Emotional Learning in Mice.

Nakamura T, Sakaue F, Nasu-Nishimura Y, Takeda Y, Matsuura K, Akiyama T EBioMedicine. 2018; 34:189-200.

PMID: 30045817 PMC: 6116350. DOI: 10.1016/j.ebiom.2018.07.011.


References
1.
du Bois T, Huang X . Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia. Brain Res Rev. 2006; 53(2):260-70. DOI: 10.1016/j.brainresrev.2006.09.001. View

2.
Ohi K, Hashimoto R, Yasuda Y, Yoshida T, Takahashi H, Iike N . Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter study. Schizophr Res. 2009; 109(1-3):80-5. DOI: 10.1016/j.schres.2009.01.019. View

3.
Kendler K, McGuire M, Gruenberg A, OHare A, SPELLMAN M, Walsh D . The Roscommon Family Study. III. Schizophrenia-related personality disorders in relatives. Arch Gen Psychiatry. 1993; 50(10):781-8. DOI: 10.1001/archpsyc.1993.01820220033004. View

4.
Stefanis N, Trikalinos T, Avramopoulos D, Smyrnis N, Evdokimidis I, Ntzani E . Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol Psychiatry. 2007; 62(7):784-92. DOI: 10.1016/j.biopsych.2006.11.015. View

5.
Stefanis N, Trikalinos T, Avramopoulos D, Smyrnis N, Evdokimidis I, Ntzani E . Association of RGS4 variants with schizotypy and cognitive endophenotypes at the population level. Behav Brain Funct. 2008; 4:46. PMC: 2572614. DOI: 10.1186/1744-9081-4-46. View